Inhibition of interleukin‐1β‐stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilage
Open Access
- 5 February 2004
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (2) , 516-525
- https://doi.org/10.1002/art.20004
Abstract
Objective To investigate the mechanism of the inhibitory action of hyaluronan (HA) on interleukin-1β (IL-1β)-stimulated production of matrix metalloproteinases (MMPs) in human articular cartilage. Methods IL-1β was added to normal and osteoarthritic (OA) human articular cartilage in explant culture to stimulate MMP production. Articular cartilage was incubated or preincubated with a clinically used form of 800-kd HA to assess its effect on IL-1β-induced MMPs. Levels of secreted MMPs 1, 3, and 13 in conditioned media were detected by immunoblotting; intracellular MMP synthesis in chondrocytes was evaluated by immunofluorescence microscopy. Penetration of HA into cartilage tissue and its binding to CD44 were analyzed by fluorescence microscopy using fluoresceinated HA. Blocking experiments with anti-CD44 antibody were performed to investigate the mechanism of action of HA. Results Treatment and pretreatment with 800-kd HA at 1 mg/ml resulted in significant suppression of IL-1β-stimulated production of MMPs 1, 3, and 13 in normal and OA cartilage explant culture. Fluorescence histocytochemistry revealed that HA penetrated cartilage tissue and localized in the pericellular matrix around chondrocytes. HA-binding blocking experiments using anti-CD44 antibody demonstrated that the association of HA with chondrocytes was mediated by CD44. Preincubation with anti-CD44 antibody, which suppressed IL-1β-stimulated MMPs, reversed the inhibitory effect of HA on MMP production that was induced by IL-1β in normal and OA cartilage. Conclusion This study demonstrates that HA effectively inhibits IL-1β-stimulated production of MMP-1, MMP-3, and MMP-13, which supports the clinical use of HA in the treatment of OA. The action of HA on IL-1β may involve direct interaction between HA and CD44 on chondrocytes.Keywords
This publication has 35 references indexed in Scilit:
- Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblastsArthritis & Rheumatism, 2000
- Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritisArthritis & Rheumatism, 2000
- Hyaluronan suppresses fibronectin fragment‐mediated damage to human cartilage explant cultures by enhancing proteoglycan synthesisJournal of Orthopaedic Research, 1999
- Osteoarthritic Lesions. Involvement of three different collagenasesArthritis & Rheumatism, 1997
- Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specificAnnals of the Rheumatic Diseases, 1997
- Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.Journal of Clinical Investigation, 1997
- Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44.Journal of Clinical Investigation, 1996
- Changes in cartilage composition and physical properties due to stromelysin degradationArthritis & Rheumatism, 1995
- Effects of hyaluronic acid on the release of proteoglycan from the cell matrix in rabbit chondrocyte cultures in the presence and absence of cytokinesArthritis & Rheumatism, 1993
- Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the kneeArthritis & Rheumatism, 1986